[go: up one dir, main page]

GB0327384D0 - Gene therapy - Google Patents

Gene therapy

Info

Publication number
GB0327384D0
GB0327384D0 GB0327384A GB0327384A GB0327384D0 GB 0327384 D0 GB0327384 D0 GB 0327384D0 GB 0327384 A GB0327384 A GB 0327384A GB 0327384 A GB0327384 A GB 0327384A GB 0327384 D0 GB0327384 D0 GB 0327384D0
Authority
GB
United Kingdom
Prior art keywords
gene therapy
therapy
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0327384A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queen Mary University of London
Original Assignee
Queen Mary and Westfiled College University of London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queen Mary and Westfiled College University of London filed Critical Queen Mary and Westfiled College University of London
Priority to GB0327384A priority Critical patent/GB0327384D0/en
Publication of GB0327384D0 publication Critical patent/GB0327384D0/en
Priority to PCT/GB2004/004963 priority patent/WO2005052164A1/en
Ceased legal-status Critical Current

Links

GB0327384A 2003-11-25 2003-11-25 Gene therapy Ceased GB0327384D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0327384A GB0327384D0 (en) 2003-11-25 2003-11-25 Gene therapy
PCT/GB2004/004963 WO2005052164A1 (en) 2003-11-25 2004-11-25 Gene therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0327384A GB0327384D0 (en) 2003-11-25 2003-11-25 Gene therapy

Publications (1)

Publication Number Publication Date
GB0327384D0 true GB0327384D0 (en) 2003-12-31

Family

ID=29797771

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0327384A Ceased GB0327384D0 (en) 2003-11-25 2003-11-25 Gene therapy

Country Status (2)

Country Link
GB (1) GB0327384D0 (en)
WO (1) WO2005052164A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1627563A1 (en) 2004-08-10 2006-02-22 Academisch Medisch Centrum bij de Universiteit van Amsterdam Means and methods for producing a stabilized cell of interest
AU2006316288B2 (en) * 2005-11-17 2012-12-20 Tet Systems Gmbh & Co. Kg Inducible expression systems
USRE49583E1 (en) 2005-11-17 2023-07-18 Tet Systems Gmbh & Co. Kg Inducible expression systems
ES2444465T5 (en) 2005-12-09 2023-11-30 Academisch Medisch Centrum Bij De Univ Van Amsterdam Means and procedures to influence the stability of antibody-producing cells
WO2007067032A1 (en) 2005-12-09 2007-06-14 Academisch Medisch Cemtrum Bij De Universiteit Van Amsterdam Means and methods for influencing the stability of cells
US20100311809A1 (en) * 2007-10-26 2010-12-09 Charite Universitaetsmedizin Berlin Viral vector system, a composition comprising the viral vector system and its use
WO2011008093A1 (en) 2009-07-15 2011-01-20 Aimm Therapeutics B.V. Means and methods for producing high affinity antibodies
NZ611600A (en) 2010-12-02 2015-02-27 Aimm Therapeutics Bv Means and methods for producing high affinity antibodies
AU2015211480B2 (en) 2014-01-31 2020-05-14 Kling Biotherapeutics B.V. Means and methods for producing stable antibodies
CN110016464A (en) * 2018-01-08 2019-07-16 张晋宇 For screening the system and method for antitumorigenic substance
JP7593639B2 (en) 2018-09-28 2024-12-03 プレジデント アンド フェローズ オブ ハーバード カレッジ Cellular reprogramming to reverse aging and promote organ and tissue regeneration
US20210403923A1 (en) * 2018-09-28 2021-12-30 President And Fellows Of Harvard College Mutant reverse tetracycline transactivators for expression of genes
US12274733B2 (en) 2018-09-28 2025-04-15 President And Fellows Of Harvard College Cellular reprogramming to reverse aging and promote organ and tissue regeneration

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003521941A (en) * 2000-02-11 2003-07-22 クイーンメリー アンド ウエストフィールド カレッジ vector
WO2001094605A2 (en) * 2000-06-09 2001-12-13 University Of Florida Research Foundation, Inc. Recombinant aav vectors for gene therapy of obesity

Also Published As

Publication number Publication date
WO2005052164A1 (en) 2005-06-09

Similar Documents

Publication Publication Date Title
GB0307918D0 (en) Therapeutic use
EP1689485A4 (en) Cardioelectromagnetic treatment
GB0303910D0 (en) Therapeutic agents
GB0312407D0 (en) Treatment
GB0327384D0 (en) Gene therapy
GB0406728D0 (en) Gene therapy
ZA200707236B (en) Microorganisms for therapy
GB0301350D0 (en) Therapeutic agents
GB0304524D0 (en) Therapeutic agents
AU2003294705A8 (en) Ntsm gene
GB2401551B (en) Stimulation aid
GB0303289D0 (en) Combination therapy
GB0312122D0 (en) Therapeutic method
GB0325021D0 (en) Therapeutic combinations
GB0326598D0 (en) Gene
GB0313773D0 (en) Gene
GB0230039D0 (en) Gene
GB0215188D0 (en) Height-related gene
GB0209640D0 (en) Height-related gene
GB0203039D0 (en) Gene
GB0316176D0 (en) Combination therapy
GB0316184D0 (en) Combination therapy
GB0318311D0 (en) Combination therapy
GB0307560D0 (en) Combination therapy
GB0314097D0 (en) Combination therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)